Subscribe To

Price Alert Latest News Economic Calendar News

STAA / STAAR Surgical Company (STAA) CEO Caren Mason on Q2 2022 Results - Earnings Call Transcript

Start Time: 16:30 January 1, 0000 5:20 PM ET STAAR Surgical Company (NASDAQ:STAA ) Q2 2022 Earnings Conference Call August 10, 2022, 16:30 PM ET Company Participants Caren Mason - President and CEO Patrick Williams - CFO Brian Moore - VP, Investor, Media Relations and Corporate Development Conference Call Participants Andrew Brackmann - William Blair Bill Plovanic - Canaccord Genuity Chris Cooley - Stephens Inc. Zach Weiner - Jefferies Ryan Zimmerman - BTIG David Saxon - Needham and Company Steven Lichtman - Oppenheimer &Co. Operator Hello, all, and thank you for standing by. Welcome to the STAAR Surgical Second Quarter Financial Results Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Staar

Surgical

Company

STAA

Caren

Mason

2022

Results

staa

Earnings

Transcript

Stock

Posted: Aug 10 2022, 21:34

Author Name: Seeking Alpha

STAA News

By Seeking Alpha
November 1, 2023

STAAR Surgical Company (STAA) Q3 2023 Earnings Call Transcript

STAAR Surgical Company (NASDAQ:STAA ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Brian Moore - Vice President-I

By Seeking Alpha
August 9, 2023

STAAR Surgical: Economic Realities Beginning To Surface, Reiterate Hold

STAAR Surgical Company's Q2 FY'23 earnings missed consensus estimates. The key revenue driver for STAA is its Implantable Collamer Lenses, which saw a

By Zacks Investment Research
August 2, 2023

Staar Surgical (STAA) Q2 Earnings Beat Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to e

By Seeking Alpha
May 26, 2023

I See Opportunity In STAAR Surgical

STAAR Surgical is on the cusp of an acceleration in earnings and growth courtesy of its entrance into the US market. It is profitable, generates posit

By Seeking Alpha
May 3, 2023

STAAR Surgical Company (STAA) Q1 2023 Earnings Call Transcript

STAAR Surgical Company (NASDAQ:STAA ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Brian Moore - VP of Investor, Media

By Seeking Alpha
February 21, 2023

STAAR Surgical Company (STAA) Q4 2022 Earnings Call Transcript

STAAR Surgical Company (NASDAQ:STAA ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Brian Moore - Vice President

By Zacks Investment Research
February 21, 2023

Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of -6.67% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers

By Zacks Investment Research
February 3, 2023

STAAR Surgical (STAA) to Report Q4 Earnings: What's in Store?

Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.